Chamber and committees

The Scottish Government’s Aviation Statement, which will be published shortly, will set out actions that the Scottish Government will take to help achieve our aviation emissions reduction targets.

Additionally, we have already set out 45 recommendations for future investment in Scotland’s strategic transport network in the second Strategic Transport Projects Review, published on 8 December 2022. Within these recommendations we have considered airport access in our strategic transport planning considerations. These have been considered in the recommendations for mass or rapid transit systems for the Glasgow, Edinburgh and Aberdeen City Regions, in the form of Clyde Metro, Edinburgh and South East Scotland Mass Transit and Aberdeen Rapid Transit. These recommendations can provide a transformational change in the service provision, focusing on strategic routes and / or corridors where bus and rail provide the most effective service. This will improve access to an affordable and reliable public transport system within these City Regions.

National Planning Framework 4 is also now in effect. Policy 13, ‘Sustainable Transport’, has a clear intent ‘to encourage, promote and facilitate developments that prioritise walking, wheeling, cycling and public transport for everyday travel and reduce the need to travel unsustainably.’ It promotes the National Transport Strategy 2 and places the climate emergency at the forefront of decision making.

The Scottish Government will consider whether to buy low emission aircraft for use on the Glasgow to Campbeltown, Tiree and Barra air services, to replace the current Highlands and Islands Airports Limited owned aircraft, when such aircraft become commercially available. Our consideration will take into account such factors as the Scottish Government’s budgetary position and the reduction in emissions that available aircraft could likely deliver.

Decisions on clinical pathways are not for the Scottish Government. These decisions are for clinicians, based on the best evidence available, through the appropriate clinical governance structures.

On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.

The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.

Decisions on clinical pathways are not for the Scottish Government. These decisions are for clinicians, based on the best evidence available, through the appropriate clinical governance structures.

The Scottish Government is unaware of any discussions between NHS Scotland Health Boards and the UK Government regarding the prescription of puberty-suppressing hormones as a treatment option for gender dysphoria.

The National Gender Identity Healthcare Reference Group continues to meet and make progress against all the commitments set out within the referenced December 2021 Strategic Action Framework. This includes:

• Healthcare Improvement Scotland developing standards for gender identity healthcare for NHS Scotland;
• NHS Education Scotland developing a Transgender Health Knowledge and Skills framework for NHS staff;
• Public Health Scotland working with Health Boards to deliver publication of waiting times data by them; and
• Grant funding to the University of Glasgow to administer a programme of research on gender identity healthcare.

The Scottish Government has had no recent discussions with the UK Government regarding Port of Cairnryan Ltd’s submission of company accounts for the year to 31 December 2022.

The term “puberty-suppressing hormones” is non-specific, and could be applied to a range of medicines used for a variety of conditions.

The Scottish Government and NHS Scotland are proactively engaged with NHS England and its commissioned research study on puberty-suppressing hormones as a treatment option for gender dysphoria. This is being delivered by the National Institute for Health Research (NIHR). The Scottish Government and the NHS in Scotland are currently observers to that ongoing study development process, however consideration by NHS partners of what further engagement with this study may be appropriate is ongoing, as the scope of the research continues to be developed and defined by NIHR.

In the context of specialist provision of gender identity healthcare to children and young people, since publication of its Strategic Action Framework for Gender Identity Service improvement in December 2021, the Scottish Government has maintained an extensive dialogue with NHS Health Boards in Scotland on how to collectively work to improve healthcare provision in this sphere.

On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.

The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.

The processing of an environmental impact assessment (EIA) scoping request under section 12 of the Electricity Works (Environmental Impact Assessment) (Scotland) Regulations 2017 involves work across a number of teams within the Energy Consents Unit.

We do not centrally log or track the specific number of working hours spent by individual team members on any particular activity or task. The work is integrated into the broader responsibilities and workflows of the team. It is therefore not possible to calculate the average number of working hours spent processing in the years requested.

The Scottish Government is not responsible for the assessment of abandoned calls to NHS 24 which is an operational matter for the Board. We monitor NHS 24 performance against a number of indicators on a weekly basis.

Calls to the 111 service can be abandoned for a variety of reasons, including callers choosing to end their call after being connected to the automated messaging service and hearing the options available to them. These include accessing self-care advice via NHS Inform, or contacting another area of the health service which may be more appropriate to meet their needs.

The Scottish Government continues to support NHS 24's ongoing work to help reduce abandoned calls, including a recent revision of NHS 24's key performance indicators to better reflect and understand the current demands on the service. This work allows the Service to capture any unmet demand, and any potential risks where callers have made multiple attempts to access 111 without success.